by Jordana Choucair | Nov 28, 2022 | Public Health/Prevention
White House health officials are projecting cautious optimism regarding the state of the COVID-19 pandemic and the spread of the respiratory syncytial virus (RSV) in the U.S. The White House’s COVID-19 response coordinator, Ashish Jha, said on ABC’s...
by Jordana Choucair | Nov 23, 2022 | Access & Coverage
The Biden administration announced that nearly 3.4 million people signed up for individual coverage on the Affordable Care Act (ACA) marketplace between November 1 to 19. Thus far, enrollment is up 17 percent from last year. The boost in enrollment comes as the number...
by Jordana Choucair | Nov 23, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved Hemgenix, an IV treatment for adults with hemophilia B. Shortly after the approval, Drugmaker CSL Behring announced that the drug costs $3.5 million a dose, making it the most expensive medicine in the world. CSL Behring...
by Jordana Choucair | Nov 23, 2022 | Public Health/Prevention
The Biden administration launched a six-week push to increase Americans’ COVID-19 booster vaccinations heading into the holiday season. The campaign will focus on reaching seniors and the communities that were hardest hit by COVID-19 by expanding access, increasing...
by Jordana Choucair | Nov 22, 2022 | Inequities and SDOH
A recent Centers for Disease Control and Prevention (CDC) analysis indicates that people with impaired vision aren’t getting the health care they need. According to the study, 50.2 percent of people with vision impairment said they had fair or poor general health...
by Jordana Choucair | Nov 22, 2022 | Opioid/Substance Use Disorders
A Kaiser Health News (KHN) article examines how states are planning to spend the $26 billion for the opioid settlement fund. The settlement includes specific parameters for how the states can spend the money: 70 percent must be used for opioid-related expenses (e.g.,...
Recent Comments